Log In
Print
BCIQ
Print
Print this Print this
 

bardoxolone methyl (RTA 402)

Also known as: CDDO-Me

  Manage Alerts
Collapse Summary General Information
Company Reata Pharmaceuticals Inc.
DescriptionSmall molecule activator of nuclear factor (erythroid-derived 2)-like 2 (NFE2L2; NRF2)
Molecular Target Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) (NRF2) ; Signal transducer and activator of transcription 3 (STAT3)
Mechanism of ActionNF-kappa B (NF-kB) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1,072.0M

$35.0M

$587.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today